Brinzo, P. N., & Martins, S. S. (2024). Racial/ethnic trends in opioid and polysubstance opioid overdose mortality in adolescents and young adults, 1999–2020. Addictive Behaviors, 156, 108065. https://doi.org/10.1016/j.addbeh.2024.108065

Cerdá, M., Hamilton, A. D., Hyder, A., Rutherford, C., Bobashev, G., Epstein, J. M., Hatna, E., Krawczyk, N., El-Bassel, N., Feaster, D. J., & Keyes, K. M. (2024). Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties. Epidemiology, 35(3), 418–429. https://doi.org/10.1097/ede.0000000000001703

O’Grady, M. A., Elkington, K. S., Robson, G., Achebe, I. Y., Williams, A. R., Cohall, A. T., Cohall, R., Christofferson, M., Garcia, A., Ramsey, K. S., Lincourt, P., & Tross, S. (2024). Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators. Substance Abuse Treatment, Prevention, and Policy, 19(1). https://doi.org/10.1186/s13011-024-00593-y

Nesoff, E. D., Meisel, Z. F., Saeed, H., & Martins, S. S. (2024). Neighborhood and Individual Disparities in Community-Based Naloxone Access for Opioid Overdose Prevention. Journal of Urban Health, 101(1), 64–74. https://doi.org/10.1007/s11524-023-00821-z

Otufowora, A., Egan, K. L., Chaudhari, P. V., Okusanya, A. A., Ogidan, A. O., & Cottler, L. B. (2023). Drug Deactivation Pouches for Primary Prevention of Opioid Overdose: Perceptions and Attitudes of Community Members. The Journal of the American Board of Family Medicine, 37(1), 112–117. https://doi.org/10.3122/jabfm.2023.230227r1

Khan, M. R., Hoff, L., Elliott, L., Scheidell, J. D., Pamplin, J. R., Townsend, T. N., Irvine, N. M., & Bennett, A. S. (2023). Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City. Harm Reduction Journal, 20(1). https://doi.org/10.1186/s12954-023-00736-7

Mannes, Z. L., Wheeler-Martin, K., Terlizzi, K., Hasin, D. S., Perry, A., Pamplin, J. R., Crystal, S., Cerdá, M., & Martins, S. S. (2023). Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic. Preventive Medicine, 177, 107789. https://doi.org/10.1016/j.ypmed.2023.107789

Tipping, A. D., Nowels, M., Moore, C., Samples, H., Crystal, S., Olfson, M., Williams, A. R., & Heaps-Woodruff, J. (2024). Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study. Journal of Substance Use and Addiction Treatment, 157, 209218. https://doi.org/10.1016/j.josat.2023.209218

Hoffman, K. L., Milazzo, F., Williams, N. T., Samples, H., Olfson, M., Diaz, I., Doan, L., Cerda, M., Crystal, S., & Rudolph, K. E. (2023). Independent and joint contributions of physical disability and chronic pain to incident opioid use disorder and opioid overdose among Medicaid patients. Psychological Medicine, 54(7), 1419–1430. https://doi.org/10.1017/s003329172300332x

Olfson, M., Cosgrove, C. M., Wall, M. M., & Blanco, C. (2023). Fatal Drug Overdose Risks of Health Care Workers in the United States. Annals of Internal Medicine, 176(8), 1081–1088. https://doi.org/10.7326/m23-0902

Samples, H., Nowels, M. A., Williams, A. R., Olfson, M., & Crystal, S. (2023). Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability Beneficiaries. American Journal of Preventive Medicine, 65(1), 19–29. https://doi.org/10.1016/j.amepre.2023.01.037

Fink, D. S., Keyes, K. M., Branas, C., Cerdá, M., Gruenwald, P., & Hasin, D. (2023). Understanding the differential effect of local socio‐economic conditions on the relation between prescription opioid supply and drug overdose deaths in US counties. Addiction, 118(6), 1072–1082. Portico. https://doi.org/10.1111/add.16123

Krawczyk, N., Rivera, B. D., Basaraba, C., Corbeil, T., Allen, B., Schultebraucks, K., Henry, B. F., Pincus, H. A., Levin, F. R., & Martinez, D. (2023). COVID‐19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems. Addiction, 118(5), 857–869. Portico. https://doi.org/10.1111/add.16105

Chandler, R., Nunes, E. V., Tan, S., Freeman, P. R., Walley, A. Y., Lofwall, M., Oga, E., Glasgow, L., Brown, J. L., Fanucchi, L., Beers, D., Hunt, T., Bowers-Sword, R., Roeber, C., Baker, T., & Winhusen, T. J. (2023). Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term SM) communities study. Drug and Alcohol Dependence, 245, 109804. https://doi.org/10.1016/j.drugalcdep.2023.109804

Luba, R., Jones, J., Choi, C. J., & Comer, S. (2022). Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance. Addiction, 118(4), 719–726. Portico. https://doi.org/10.1111/add.16100

Sacco, D. L., & Martins, S. S. (2022). Characteristics of Nonfatal Opioid Overdose in Emergency Department Patients Surviving to Discharge or Hospital Admission. Journal of Studies on Alcohol and Drugs. https://doi.org/10.15288/jsad.22-00204

Nesoff, E. D., Wiebe, D. J., & Martins, S. S. (2022). City streetscapes and neighborhood characteristics of fatal opioid overdoses among people experiencing homelessness who use drugs in New York City, 2017–2019. International Journal of Drug Policy, 110, 103904. https://doi.org/10.1016/j.drugpo.2022.103904

Paschen-Wolff, M. M., Velasquez, R., Aydinoglo, N., & Campbell, A. N. C. (2022). Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States. Journal of Substance Abuse Treatment, 140, 108828. https://doi.org/10.1016/j.jsat.2022.108828

Rudolph, K. E., Gimbrone, C., Matthay, E. C., Díaz, I., Davis, C. S., Keyes, K., & Cerdá, M. (2022). When Effects Cannot be Estimated: Redefining Estimands to Understand the Effects of Naloxone Access Laws. Epidemiology, 33(5), 689–698. https://doi.org/10.1097/ede.0000000000001502

Samples, H., Williams, A. R., Crystal, S., & Olfson, M. (2022). Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes. Journal of Substance Abuse Treatment, 139, 108774. https://doi.org/10.1016/j.jsat.2022.108774

Jones, J. D., Campbell, A. N., Brandt, L., Metz, V. E., Martinez, S., Wall, M., Corbeil, T., Andrews, H., Castillo, F., Neale, J., Strang, J., Ross, S., & Comer, S. D. (2022). A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder. Drug and Alcohol Dependence, 237, 109505. https://doi.org/10.1016/j.drugalcdep.2022.109505

Crystal, S., Nowels, M., Samples, H., Olfson, M., Williams, A. R., & Treitler, P. (2022). Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients. Drug and Alcohol Dependence, 232, 109269. https://doi.org/10.1016/j.drugalcdep.2022.109269